Assertio agrees to $125.1 million Garda Therapeutics acquisition

April 8, 2026 4:04 PM

Assertio Holdings Inc. (NASDAQ: ASRT) announced a definitive agreement to be acquired by Garda Therapeutics for $18 per share in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found